医療関係者の方へ 診療科案内

ホームへ戻る

肝臓・胆道・膵臓英論文

2020

  1. A multicenter prospective registration study on laparoscopic pancreatectomy in Japan: report on the assessment of 1,429 patients Ohtsuka T, Nagakawa Y, Toyama H, Takeda Y, Maeda A, Kumamoto Y, Nakamura Y, Hashida K, Honda G, Furukawa K, Toyoda E, Tanabe M, Gotohda N, Matsumoto I, Ryu T, Uyama I, Kojima T, Unno M, Ichikawa D, Inoue Y, Matsukawa H, Sudo T, Takaori K, Yamaue H, Eguchi S, Tahara M, Shinzeki M, Eguchi H, Kurata M, Morimoto M, Hayashi H, Marubashi S, Inomata M, Kimura K, Amaya K, Sho M, Yoshida R, Murata A, Yoshitomi H, Hakamada K, Yasunaga M, Abe N, Hioki M, Tsuchiya M, Misawa T, Seyama Y, Noshiro H, Sakamoto E, Hasegawa K, Kawabata Y, Uchida Y, Kameyama S, Ko S, Takao T, Kitahara K, Nakahira S, Baba H, Watanabe M, Yamamoto M, Nakamura M J Hepatobiliary Pancreat Sci 27:47-55, 2020

2019

  1. The association of airway comorbidities with the clinical phenotypes and outcomes of ANCA-associated vasculitis patients. Ono N, Inoue Y, Miyamura T, Ueda N, Nagano S, Inoue H, Oryoji K, Ota SI, Sawabe T, Yoshizawa S, Takeyama Y, Sadanaga Y, Takamori A, Kimoto Y, Miyake K, Horiuchi T, Nakashima H, Niiro H, Tada Y. J Rheumatol 2019 2019 Sep 15. pii: jrheum.190373. doi: 10.3899/jrheum.190373. [Epub ahead of print]
  2. Conversion surgery after extensive chemotherapy for stage IV mixed adenoneuroendocrine carcinoma (MANEC) of the gallbladder: clinical implication from patterns of response and recurrence. Kamei K, Shindoh J, Kiya Y, Matsumoto I, Hashimoto M, Takeyama Y Clin J Gastroenterol 2019 Oct 15. doi: 10.1007/s12328-019-01053-y. [Epub ahead of print]
  3. Preoperative risk assessment for loss of independence following hepatic resection in elderly patients: A prospective multicenter study. Tanaka S, Iida H, Ueno M, Hirokawa F, Nomi T, Nakai T, Kaibori M, Ikoma H, Eguchi H, Shinkawa H, Maehira H, Hayami S, Kubo S. Ann Surg 2019 Aug 23. doi: 10.1097/SLA.0000000000003585. [Epub ahead of print]
  4. Laparoscopic versus open liver resection for hepatocellular carcinoma in elderly patients: A multi-center preoperative score-based analysis. Nomi T, Hirokawa F, Kaibori M, Ueno M, Tanaka S, Hokuto D, Noda T, Nakai T, Matsumoto M, Morimura R, Maehira H, Sho M, Kubo S. Surg Endosc 34:658-666, 2020
  5. Continuous regional arterial infusion versus intravenous administration of the protease inhibitor nafamostat mesylate for predicted severe acute pancreatitis: a multicenter, randomized, open-label, phase 2 trial. Hirota M, Shimosegawa T, Kitamura K, Takeda K, Takeyama Y, Mayumi T, Ito T, Takenaka M, Iwasaki E, Sawano H, Ishida E, Miura S, Masamune A, Nakai Y, Mitoro A, Maguchi H, Kimura K, Sanuki T, Ito T, Haradome H, Kozaka K, Gabata T, Kataoka K, Hirota M, Isaji S, Nakamura R, Yamagiwa K, Kayaba C, Ikeda K. J Gastroenterol 55:342-352, 2019
  6. Transpancreatic mattress suture with Vicryl mesh around the stump decreases postoperative pancreatic fistula after distal pancreatectomy Yoshida Y, Matsumoto I, Matsumoto M, Kawaguchi K, Murase T, Kamei K, Satoi S, Takebe A, Nakai T, Takeyama Y J Hepatobiliary Pancreat Sci 26:510-516, 2019
  7. Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predicts a better prognosis for patients with pancreatic adenocarcinoma: a multicenter case-control study of 240 patients Aoki S, Murakami Y, Sho M, Honda G, Uemura K, Okada K, Matsumoto I, Nagai M, Yanagimoto H, Kurata M, Fukumoto T, Mizuma M, Yamaue H, Unno M BMC Cancer 19:252, 2019
  8. A prospective, randomized phase II study of adjuvant gemcitabine versus S-1 after major heapatectomy for biliary tract cancer (KHBO 1208): Kansai Hepato-Biliary Oncology Group Kobayashi S, Nagano H, Tomokuni A, Gotoh K, Sakai D, Hatano E, Seo S, Terajima H, Uchida Y, Ajiki T, Satake H, Kamei K, Tohyama T, Hirose T, Ikai I, Morita S, Ioka T, Kansai Hepato-Biliary Oncology (KHBO) Group. Ann Surg 270: 230-237, 2019
  9. The impact of UGT1A1 genetic polymorphism on toxicity in unresectable pancreatic cancer patients undergoing FOLFIRINOX Shirasu H, Todaka A, Omae H, Fujii H, Mizuno N, Ozaka M, Ueno H, Kobayashi S, Uesugi K, Kobayashi N, Hayashi H, Sudo K, Okano N, Horita Y, Kamei K, Yukisawa S, Kobayashi M, Fukutomi A. Cancer Sci 110: 707-716, 2019
  10. Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP-05) Motoi F, Kosuge T, Ueno H, Yamaue H, Satoi S, Sho M, Honda G, Matsumoto I, Wada K, Furuse J, Matsuyama Y, Unno. The Study Group of Preoperative Therapy for Pancreatic Cancer (Prep) and Japanese Study Group of Adjuvant Therapy for Pancreatic cancer (JSAP). Jpn J Clin Oncol 49: 190-194, 2019
  11. A single-arm, phase II trial of neoadjuvant gemcitabine and S1 in patients with resectable and borderline resectable pancreatic adenocarcinoma: PREP-01 study. Motoi F, Satoi S, Honda G, Wada K, Shinchi H, Matsumoto I, Sho M, Tsuchida A, Unno M, For the Study Group of Preoperative therapy for Pancreatic cancer (PREP) J Gastroenterol 54: 194-203, 2019
  12. Sustained elevation of postoperative serum level of carbohydrate antigen 19-9 is high-risk stigmata for primary hepatic recurrence in patients with curatively resected pancreatic adenocarcinoma. Motoi F, Murakami Y, Okada KI, Matsumoto I, Uemura K, Satoi S, Sho M, Honda G, Fukumoto T, Yanagimoto H, Kinoshita S, Kurata M, Aoki S, Mizuma M, Yamaue H, Unno M; Multicenter Study Group of Pancreatobiliary Surgery (MSG-PBS) World J Surg 43: 634-641, 2019
  13. Laparoscopic versus open distal pancreatectomy for benign and low-grade malignant lesions of the pancreas: a single-center comparative study. Matsumoto I, Kamei K, Satoi S, Murase T, Matsumoto M, Kawaguchi K, Yoshida Y, Iwasaki T, Takebe A, Nakai T, Takeyama Y. Surgery Today 49: 394-400, 2019
  14. FOLFIRINOX for locally advanced pancreatic cancer: results and prognostic factors of subset analysis from a nation-wide multicenter observational study in Japan. Matsumoto I, Kamei K, Omae K, Suzuki S, Matsuoka H, Mizuno N, Ozaka M, Ueno H, Kobayashi S, Uesugi K, Kobayashi M, Todaka A, Fukutomi A Pancreatology 19: 296-301, 2019
  15. Laparoscopic distal pancreatectomy for elderly patients. Matsumoto I, Kamei K, Takebe A, Takeyama Y. Laparosc Surg 3:13, 2019
  16. Identification of aberrant subvesical bile duct by using intraoperative fuluorescent cholangiography: A case report Iwasaki T, Takeyama Y, Yoshida Y, Kawaguchi, Matsumoto M, Murase T, Kamei K, Takebe A, Matsumoto I, Nakai T Int J Surg Case Rep 61:115-118, 2019
  17. A synonymous VHL variation in exon 2 confuse susceptibility to familial phenochromocytoma and Von Hippel-Lindau Disease. Flores K, Cheng Z, Jasper AM, Natori K, Okamoto T, Tanabe A, Gotoh K, Shibata H, Sakurai A, Nakai T, Wang X, Zethoven M, Balachander S, Aita Y, Young W, Zheng S, Takekoshi K, Nakamura E, Tothill RW, Aruiar RCT, Patricia LM, Dahia PLM. J Clin Endocrinol Metab 104: 3826-3834, 2019
  18. POGLUT1, the putative effector gene driven by rs22993370 in primary biliary cholamgitis susceptibility locus chromosome 3q13.33. Hitomi Y, Ueno K, Kawai Y, Nishida N, Kojima K, Kawashima M, Aiba Y, Nakamura H, Kouno H, Kouno H, Ohta H, Sugi K, Nikami T, Yamashita T, Katsushima S, Komeda T, Ario K, Naganuma A, Shimada M, Hirashima N, Yoshizawa K, Makita F, Furuta K, Kikuchi M, Naeshiro N, Takahashi H, Mano Y, Yamashita H, Matsushita K, Tsunematsu S, Yabuuchi I, Nishimura H, Shimada Y, Yamauchi K, Komatsu T, Sugimoto R, Sakai H, Mita E, Koda M, Nakamura Y, Kamitsukasa H, Sato T, Nakamuta M, Masaki N, Takikawa H, Tanaka A, Ohira H, Zeniya M, Abe M, Kaneko S, Honda M, Arai K, Arinaga-Hino T, Hashimoto E, Taniai M, Umemura T, Joshita S, Nakao K, Ichikawa T, Shibata H, Takaki A, Yamagiwa S, Seike M, Sakisaka S, Takeyama Y, Harada M, Senju M, Yokosuka O, Kanda T, Ueno Y, Ebinuma H, Himoto T, Murata K, Shimoda S, Nagaoka S, Abiru S, Komori A, Migita K, Ito M, Yatsuhashi H, Maehara Y, Uemoto S, Kokudo N, Nagasaki M, Tokunaga K, Nakamura M. Sci Rep 14: 102, 2019
  19. Usefulness of urinary trypsinogen-2 and trypsinogen activation peptide in acute pancreatitis: A multicenter study in Japan. Yasuda H, Kataoka K, Takeyama Y, Takeda K, Ito T, Mayumi T, Isaji S, Mine T, Kitagawa M, Kiriyama S, Sakagami J, Masamune A, Inui K, Hirano K, Akashi R, Yokoe M, Sogame Y, Okazaki K, Morioka C, Kihara Y, Kawa S, Tanaka M, Andoh A, Kimura W, Nishimori I, Furuse J, Yokota I, Shimosegawa T. World J Gastroenterol. 7: 107-117, 2019
  20. Effects of oral morphine on dyspnea in patients with cancer: Response rate predictive factors, and clinically meaningful change (CJLSG1101). Takahashi K, Kondo M, Ando M, Shiraki A, Nakashima H, Wakayama H, Kataoka K, Yamamoto M, Sugino Y, Nishikawa M, Imaizumi K, Kojima E, Sumida A, Takeyama Y, Saito H, Hasegawa Y. Oncologist 24: e583-e589, 2019
  21. IL28B gene polymorphism is correlated with changes in low-density lipoprotein cholesterol levels after clearance of hepatitis C virus using direct-acting antiviral treatment. Morihara D, Ko YL, Shibata K, Yamauchi R, Fukuda H, Tsuchiya N, Fukunaga A, Kunimoto H, Iwashita H, Takata K, Tanaka T, Sakurai K, Inomata S, Yokoyama K, Nishizawa S, Takeyama Y, Irie M, Shakado S, Sohda T, Sakisaka S. J Gastroenterol Hepatol. 34: 2019-2027, 2019
  22. Changes in the serum hepcidin-to-ferritin ratio with erythroferrone after hepatitis C virus eradication using direct-acting antiviral agents. Inomata S, Anan A, Yamauchi E, Yamauchi R, Kunimoto H, Takata K, Tanaka T, Yokoyama K, Morihara D, Takeyama Y, Irie M, Shakado S, Sohda T, Sakisaka S. Intern Med. 58: 2915-2922, 2019
  23. Prispective study of early chronic pancreatitis diagnosed based on the Japanese diagnostic criteria. Masamune A, Nabeshima T, Kikuta K, Hamada S, Nakano E, Kume K, Kanno A, Sato A, Tachibana Y, Inatomi O, Yamamoto S, Ikeura T, Futagami S, Taguchi M, Hanada K, Shimizu K, Kageoka M, Saito T, Eguchi T, Kubota K, Takenaka M, Mima A, Irisawa A, Ito T, Andoh A, Inui K, Takeyama Y, Yamaue H, Okazaki K, Shimosegawa T. J Gastroenterol 54: 928-935, 2019
  24. Elderly-onset acute necrotizing encephalopathy mimicking severe heat stroke: a case report and review of the literature. Odagiri A, Yamaoka A, Miyata K, Bunya N, Kasai T, Takeyama Y, Uemura S, Mikami T, Narimatsu E. 6: 316-320, 2019

2018

  1. Nationwide multicenter observantional study of FOLFIRINOX chemotherapy in 399 patients with unresectable or recurrent pancreatic cancer in Japan. Todaka A, Mizuno N, Ozaka M, Ueno H, Kobayashi S, Usesugi K, Kobayashi N, Hayashi H, Sudo K, Okano N, Horita Y, Kamei K, Yukisawa S, Nakamori S, Yachi Y, Henmi T, Kobayashi M, Boku N, Mori K, Fukutomi A Pancreas 47(5): 631-636, 2018
  2. Is distal pancreatectomy with en-bloc celiac axis resection effective for patients with locally advanced pancreatic ductal adenocarcinoma? -Multicenter surgical group study. Yamamoto T, Satoi S, Kawai M, Motoi F, Sho M, Uemura K, Matsumoto I, Honda G, Okada K, Akahori T, Toyama H, Kurata M, Yanagimoto H, Yamaue H, Unno M, Kon M, Murakami Y Pancreatology Pancreatology 18(1): 106-113, 2018
  3. Impact of avascular areas, as measured by contrast-enhanced harmonic EUS, on the accuracy of fine-needle aspiration for pancreatic adenocarcinoma. Kamata K, Takenaka M, Omoto S, Miyata T, Minaga K, Yamao K, Imai H, Sakurai T, Nishida N, Chikugo T, Chiba Y, Matsumoto I, Takeyama Y, Kudo M. Gastrointest Endosc 87(1): 158-163, 2018
  4. Perioperative allogenic blood transfuseon is a poor prognostic factor after hepatocellular carcinoma surgery: a multi-center analysis. Wada H, Eguchi H, Nagano H, Kubo S, Nakai T, Kaibori M, Hayashi M, Takemura S, Tanaka S, Nakata Y, Matsui K, Ishizaki M, Hirokawa F, Komeda K, Uchiyama K, Kon M, Doki Y, Mori M. Surg Today 48(1): 73-79, 2018
  5. Contrast-enhanced harmonic endoscopic ultrasonography for differential diagnosis of localized gallbladder lesions. Kamata K, Takenaka M, Kitano M, Omoto S, Miyata T, Minaga K, Yamao K, Imai H, Sakurai T, Nishida N, Kashida H, Chikugo T, Chiba Y, Nakai T, Takeyama Y, Lisotti A, Fusaroli P, Kudo M. Dig Endosc 30(1): 98-106, 2018
  6. Insulin deficiency with and without glucagon: A comparative study between total pancreatectomy and type 1 diabetes. Niwano F, Hiromine Y, Noso S, Babaya N, Ito H, Yasutake S, Matsumoto I, Takeyama Y, Kawabata Y, Ikegami H. J Diabetes Investig 9:1084-1090, 2018
  7. Management of Pancreatolithiasis: A Nationwide Survey in Japan. Inui K, Masamune A, Igarashi Y, Ohara H, Tazuma S, Sugiyama M, Suzuki Y, Miyoshi H, Yamamoto S, Takeyama Y, Nakano E, Takuma K, Sakagami J, Hayashi K, Kogure A, Ito T, Mukai T, Maetani I, Nagahama M, Serikawa M, Ueki T, Furuya K, Isayama H, Morikawa I, Shigeno M, Mizukami K, Nanashima A, Oana S, Ikehata A, Watanabe N, Hirooka Y, Ogoshi K, Sasaki Y, Iwata Y, Kudo Y, Nakayama A, Nakamura M. Pancreas 47:708-714, 2018
  8. Clinical course of type 1 autoimmune pancreatitis patients without steroid treatment: a Japanese multicenter study of 97 patients. Kubota K, Kamisawa T, Hirano K, Hirooka Y, Uchida K, Ikeura T, Ahiomi H, Ohara H, Shimizu K, Arakura N, Kanno A, Sakagami J, Itoi T, Ito T, Ueki T, Nishino T, Inui K, Mizuno N, Yoshida H, Sugiyama M, Iwasaki E, Irisawa A, Okazaki K, Kawa S, Shinosegawa T, Takeyama Y, Chiba T. J Hepatobiliary Pancreat Sci 25:223-230, 2018
  9. Nationwide survey of hereditary pancreatitis in Japan. Masamune A, kikuta K, Hamada S, Nakano E, Kume K, Inui A, Shimizu T, Takeyama Y, Nio M, Shinosegawa T. J gastroenterol 53:152-160, 2018
  10. Health-related quality of life of adjuvant chemotherapy with S-1 versus gemcitabine for resected pancreatic cancer: Results from a randomized phase III Trial (JASPAC 01)
    Hagiwara Y, Ohashi Y, Uesaka K, Boku N, Fukutomi A, Okamura Y, Konishi M, Matsumoto I, Kaneoka Y, Shimizu Y, Nakamori S, Sakamoto H, Morinaga S, Kainuma O, Imai K, Sata N, Hishinuma S, Ojima H, Yamaguchi R, Hirano S, Sudo T; JASPAC 01 Study Group Eur J Cancer 93:79-88, 2018
  11. Clinical impact of developing better practices at the institutional level on surgical outcomes after distal pancreatectomy in 1,515 patients: Domestic audit of the Japanese Society of Pancreatic Surgery. Satoi S, Yamamoto T, Motoi F, Matsumoto I, Yoshitomi H, Amano R, Tahara M, Murakami Y, Arimitsu H, Hirono S, Sho M, Ryota H, Ohtsuka M, Unno M, Takeyama Y, Yamaue H. Ann Gastroenterol Surg 2:212-219, 2018
  12. Value of additional endoscopic ultrasonography for surveillance after surgical removal of intraductal papillary mucinous neoplasms. Kamata K, Takenaka M, Minaga K, Omoto S, Miyata T, Yamao K, Imai H, Nakai A, Tanaka H, Chiba Y, Watanabe T, Sakurai T, Nishida N, Chikugo T, Matsumoto I, Takeyama Y, Kitano M, Kudo M. Dig Endosc 30:659-666, 2018
  13. Laparoscopic single-site and robotic distal pancreatectomy. Matsumoto I. Laparosc Surg 2:19, 2018
  14. Growth velocity of the portal vein tumor thrombus accelerated by its progression, alpha-fetoprotein level, and liver fibrosis stage in patients with hepatocellular carcinoma. Gon H, Kido M, Tanaka M, Kinishita H, Komatsu S, Tsugawa D, Awazu M, Toyama H, Matsumoto I, Itoh, Fukumoto T. Surgery 2018; 164: 1014-1022
  15. Contrast-enhanced harmonic endoscopic ultrasonography for differential diagnosis of localized gallbladder lesions. Kamata K, Takenaka M, Kitanao M, Omoto S, Miyata T, Minaga K, Yamao K, Imai H, Sakurai T, Nishida N, Kashida H, Chikugo T, Chiba Y, Nakai T, Takeyama Y, Lisotti A, Fusaroli P, Kudo M, Dig Endosc 30:98-106, 2018
  16. Neurilemmona mimicking a multilocular cystic lesion of the liver. Yoshida A, Yamao K, Takenaka M, Nakai A, Omoto S, Kamata K, Minaga K, Miyata T, Imai H, Matsumoto I, Takeyama Y, Chikugo T, Kudo M. Intern Med 57: 3377-3380, 2018
  17. Prognostic factors of hepatectomy in initially unresectable colorectal liver metastasis: Indication for conversion surgery. Iida H, Kaibori M, Wada H, Hirokawa F, Nakai T, Kinoshita M, Hayashi M, Eguchi H, Kubo S. Mol Clin Oncol 9: 545-552, 2018
  18. Preoperative assessment of frailty predicts age-related events after hepatic resection: a prospective multicenter study. Tanaka S, Ueno M, Iida H, Nomi T, Hirokawa F, Ikoma H, Nakai T, Eguchi H, Kubo S. J Hepatobiliary Pancreat Sci 25: 377-387, 2018
  19. Clinicopathological features and prognosis of primary GISTs with tumor rupture in the real world. Nishida T, Cho H, Hirota S, Masuzawa T, Chiguchi G, Tsujinaka T; Kinki GIST Study Group: Nakai T et al. Ann Surg Oncol 25: 1961-1967, 2018

2017

  1. Low-dose maintenance steroid treatment could reduce the relapse rate in patients with type 1 autoimmune pancreatitis: a long-term Japanese multicenter analysis of 510 patients. Kubota K, Kamisawa T, Okazaki K, Kawa S, Hirano K, Hirooka Y, Uchida K, Shiomi H, Ohara H, Shimizu K, Arakura N, Kanno A, Sakagami J, Itoi T, Ito T, Ueki T, Nishino T, Inui K, Mizuno N, Yoshida H, Sugiyama M, Iwasaki E, Irisawa A, Shimosegawa T, Takeyama Y, Chiba T. J Gastroenterol 52(8): 955-964, 2017
  2. Nationwide epidemiological survey of early chronic pancreatitis in Japan. Masamune A, Kikuta K, Nabeshima T, Nakano E, Hirota M, Kanno A, Kume K, Hamada S, Ito T, Fujita M, Irisawa A, Nakashima M, Hanada K, Eguchi T, Kato R, Inatomi O, Shirane A, Takeyama Y, Tsuji I, Shimosegawa T; Research Committee of Intractable Pancreatic Diseases in Japan. J Gastroenterol 52(8): 992-1000, 2017
  3. Clinical practice guideline for post-ERCP pancreatitis. Mine T, Morizane T, Kawaguchi Y, Akashi R, Hanada K, Ito T, Kanno A, Kida M, Miyagawa H, Yamaguchi T, Mayumi T, Takeyama Y, Shimosegawa T. J Gastroenterol 52: 1013-1022, 2017
  4. Primary heaptic adenosquamous carcinoma associated with primary sclerasing cholangitis. Yamao K, Takenaka M, Imai H, Nakai A, Omoto S, Kamata K, Minaga K, Miyata T, Sakurai T, Watanabe T, Nishida N, Matsumoto I, Takeyama Y, Chikugo T, Kudo M Oncology 93(suppl 1): 76-80, 2017
  5. Detection of high-grade pancreatic intraepithelial neoplasia without morphological changes of the main pancreatic duct over a long period: Importance for close follow-up for confirmation. Yamao K, Takenaka M, Imai H, Nakai A, Omoto S, Kamata K, Minaga K, Miyata T, Sakurai T, Watanabe T, Nishida N, Matsumoto I, Takeyama Y, Chikugo T, Kudo M Oncology 93(suppl 1): 81-86, 2017
  6. Association between the risk factors for pancreatic ductal adenocarcinoma and those for malignant intraductal papillary mucinous neoplasm. Kamata K, Takenaka M, Nkai A, Omoto S, Miyata T, Minaga K, Matsuda T, Yamao K, Imai H, Chiba Y, Sakurai T, Watanabe T, Nishida N, Chikugo T, Matsumoto I, Takeyama Y, Kudo M Oncology 93(suppl 1): 102-106, 2017
  7. Malignant transformation of hepatocellular adenoma. Kwok WY, Hagiwara S, Nishida N, Watanabe T, Sakurai T, Ida H, Minami Y, Takita M, Minami T, Iwanishi M, Chishina H, Kono M, Ueshima K, Komeda Y, Arizumi T, Enoki E, Nakai T, Kumabe T, Nakashima O, Kondo F, Kudo M. Oncology 92(suppl 1): 16-28, 2017
  8. Reinforced staplers for distal pancreastectomy. Kawai M, Hirono S, Okada KI, Satoi S, Yanagimoto H, Kon M, Murakami Y, Kondo N, Sho M, Akahori T, Toyama H, Fukumoto T, Fujii T, Matsumoto I, Eguchi H, Ikoma H, Takeda Y, Fujimoto J, Yamaue H Langenbecks Arch Surg 402: 1197-1204, 2017
  9. Effect of neoadjuvant nab-paclitaxel plus gemcitabine therapy on overall survival in patients with borderline resectable pancreatic adenocarcinoma: a prospective multicenter phase II trial (NAC-GA Trial). Okada KI, Shimokawa T, Hirono S, Kawai M, Sho M, Satoi S, Matsumoto I, Eguchi H, Murakami Y, Yamada S, Doi M, Yamaue H; NAC-GA investigators Oncology 93(5): 343-346, 2017
  10. Proposed nomogram predicting the individual risk of malignancy in the patients with branch duct type intraductal papillary mucinous neoplasms of the pancreas. Jang JY, Park T, Lee S, Kim Y, Lee SY, Kim SW, Kim SC, Song KB, Yamamoto M, Hatori T, Hirono S, Satoi S, Fujii T, Hirano S, Hashimoto Y, Shimizu Y, Choi DW, Choi SH, Heo JS, Motoi F, Matsumoto I, Lee WJ, Kang CM, Han HS, Yoon YS, Sho M, Nagano H, Honda G, Kim SG, Yu HC, Chung JC, Nagakawa Y, Seo HI, Yamaue H. Ann Surg 266: 1062-1068, 2017
  11. Developing better practices at the institutional level leads to better outcomes after pancreaticoduodenectomy in 3,378 patients: domestic audit of the Japanese Society of Pancreatic Surgery. Satoi S, Yamamoto T, Yoshitomi H, Motoi F, Kawai M, Fujii T, Wada K, Arimitsu H, Sho M, Matsumoto I, Hirano S, Yanagimoto H, Ohtsuka M, Unno M, Yamaue H, Kon M. J Hepatobiliary Pancreat Sci 24: 501-510, 2017
  12. Hemorrhagic and thromboembolic complications after hepato-billiary-pancreatic surgery in patients receiving antithrombotic therapy. Ishida J, Fukumoto T, Kido M, Matsumoto I, Ajiki T, Kawai H, Hirata K, Ku Y. Dig Surg 34(2): 114-124, 2017
  13. Pancreatic duct involvement in well-differentiated neuroendocrine tumor is an independent poor prognostic factor. Nanno Y, Matsumoto I, Zen Y, Otani K, Uemura J, Toyama H, Asari S, Goto T, Ajiki T, Okano K, Suzuki Y, Takeyama Y, Fukumoto T, Ku Y. Ann Surg Oncol 24(4): 1127-1133, 2017
  14. Baseline plasma chromogranin A levels in patients with well-differentiated neuroendocrine tumors of the pancreas: A potential predictor of postoperative recurrence. Nanno Y, Toyama H, Matsumoto I, Otani K, Asari S, Goto T, Ajiki T, Zen Y, Fukumoto T, Ku Y. Pancreatology 17: 291-294, 2017
  15. Retrospective study of the correlation between pathological tumor size and survival after curative resection of T3 pancreatic adenocarcinoma: Proposal for reclassification of the tumor extending beyond the pancreas based on tumor size. Kurata M, Honda G, Murakami Y, Uemura K, Satoi S, Motoi F, Sho M, Matsumoto I, Kawai M, Yanagimoto H, Fukumoto T, Nagai M, Gosho M, Unno M, Yamaue H, for the Multicenter Study Group of Pancreatobiliary Surgery (MSG-PBS) World J Surg 41(11): 2867-2875, 2017
  16. Utility of amplatzer vascular plug with preoperative common hepatic artery embolization for distal pancreatectomy with en bloc celiac axis resection. Toguchi M, Tsurusaki M, Numoto I, Hidaka S, Yamakawa M, Asato N, Im S, Yagyu Y, Matsuki M, Takeyama Y, Murakami T. Cardiovasc Intervent Radiol 40(3): 445-449, 2017
  17. Low incidence of lymph node metastasis after resection of hepatitis virus-related intrahepatic cholangiocarcinoma.
    Iida H, Kaibori M, Tanaka S, Takemura S, Wada H, Hirokawa F, Nakai T, Hayashi M, Eguchi H, Kubo S. World J Surg 41(4): 1082-1088, 2017

2016

  1. Trans-pancreatic mattress suture with Vicrl Mesh around the stump during distal pancreatectomy: A novel technique for preventing postoperative pancreatic fistula. Matsumoto I, Takeyama Y, Kamei K, Satoi S, Nakata Y, Ishikawa H, Murase T, Matsumoto M, Nakai T. J Am Coll Surg 223(2): e1-5, 2016
  2. Pancreaticogastrostomy prevents postoperative pancreatic fistula of portal annular pancreas during pancreaticoduodenectomy. Matsumoto I, Kamei K, Satoi S, Nakai T, Takeyama Y. Int Surg 101: 550-553, 2016
  3. Mucinous cystic neoplasm of the pancreas in a male patient diagnosed by endoscopic ultrasonography. Kamei K, Matsumoto I, Takeyama Y. JOP 17(2): 216, 2016
  4. Evidence-based clinical practice guidelines for chronic pancreatitis 2015. Ito T, Ishiguro H, Ohara H, Kamisawa T, Sakagami J, Sata N, Takeyama Y, Hirota M, Miyakawa H, Igarashi H, Lee L, Fujiyama T, Hijioka M, Ueda K, Tachibana Y, Sogame Y, Yasuda H, Kato R, Kataoka K, Shiratori K, Sugiyama M, Okazaki K, Kawa S, Tando Y, Kinoshita Y, Watanabe M, Shimosegawa T. J Gastroenterol 52(2): 85-92, 2016
  5. Contrast-enhanced harmonic endoscopic ultrasonography for assessment of lymph node metastases in pancreatobiliary carcinoma. Miyata T, Kitano M, Omoto S, Kadosaka K, Kamata K, Imai H, Sakamoto H, Nisida N, Harwani Y, Murakami T, Takeyama Y, Chiba Y, Kudo M. World J Gastroenterol 22 (12): 3381-3391, 2016
  6. Utility of Amplatzer vascular plug with preoperative common heaptic artery embolization for distal pancreatectomy with enbloc celiac axisresection. Toguchi M, Tsurusaki M, Numoto I, Hidaka S, Yamakawa M, Asato N, Im S, Yagyu Y, Matsuki M, Takeyama Y, Murakami T. Cardiovasc Intervent Radiol 40: 445-449, 2016
  7. Surgical outcomes for the ruptured hepatocellular carcinoma: multicenter analysis with a case-controlled study. Tanaka S, Kaibori M, Ueno M, Wada H, Hirokawa F, Nakai T, Iida H, Eguchi H, Hayashi M, Kubo S. J Gastroentest Surg 20(12): 2021-2034, 2016
  8. Questionnaire survey on work motivations of gastrointestinal and hepatobiliary pancreatic surgeons enrolled in a Japanese national interdisciplinary program. Kaibori M, Nitta H, Hayashi M, Takemura S, Nagano H, Matsui K, Ikoma H, Nakai T, Yasunaga M, Kido M, Aoki T, Rikiyama T, Sano K, Kudo A, Katagiri S, Otsuka Y, Kuroki T, Nomi T, Yano K, Endo I, Ueno M, Kanazawa A, Terajima H, Ko S, Honda G, Seyama Y, Sunagawa H, Aibara T. J Hepatobiliary Pancreat Sci 23(11): 697-702, 2016
  9. Survival outcome of salvage hepatectomy in patients with local, recurrent hepatocellular carcinoma who underwent radiofrequency ablation as their first treatment. Ueno M, Nakai T, Hayashi M, Hirokawa F, Nagano H, Wada H, Kaibori M, Matsui K, Tanaka S, Yamaue H, Kubo S. Surgery 160(3): 661-670, 2016
  10. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios. Asari S, Matsumoto I, Toyama H, Shinzeki M, Goto T, Ishida J, Ajiki T, Fukumoto T, Ku Y. Surgery Today 46: 583-592, 2016
  11. Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumor of the Pancreas). Jais B, Rebours V, Malleo G, Salvia R, Fontana M, Maggino L, Bassi C, Manfredi R, Moran R, Lennon AM, Zaheer A, Wolfgang C, Hruban R, Marchegiani G, Fernández Del Castillo C, Brugge W, Ha Y, Kim MH, Oh D, Hirai I, Kimura W, Jang JY, Kim SW, Jung W, Kang H, Song SY, Kang CM, Lee WJ, Crippa S, Falconi M, Gomatos I, Neoptelomos J, Milanetto AC, Sperti C, Ricci C, Casadei R, Bissolati M, Balzano G, Frigerio I, Girelli R, Delhaye M, Bernier B, Wang H, Jang KT, Song DH, Huggett MT, Oppong KW, Pererva L, Kopchak KV, Del Chiaro M, Segersvard R, Lee LS, Conwell D, Osvaldt A, Campos V, Aguero Garcete G, Napoleon B, Matsumoto I, Shinzeki M, Bolado F, Fernandez JM, Keane MG, Pereira SP, Acuna IA, Vaquero EC, Angiolini MR, Zerbi A, Tang J, Leong RW, Faccinetto A, Morana G, Petrone MC, Arcidiacono PG, Moon JH, Choi HJ, Gill RS, Pavey D, Ouaïssi M, Sastre B, Spandre M, De Angelis CG, Rios-Vives MA, Concepcion-Martin M, Ikeura T, Okazaki K, Frulloni L, Messina O, Lévy P. Gut 65(2): 305-312, 2016
  12. Contrast-enhanced harmonic endoscopic ultrasonography for differential diagnosis of pancreatic cysts.Kamata K, Kitano M, Omoto S, Kadosaka K, Miyata T, Yamao K, Imai H, Sakamoto H, Harwani Y, Chikugo T, Chiba Y, Matsumoto I, Takeyama Y, Kudo M. Endoscopy 48(1): 35-41, 2016
  13. Anatomical variations of liver blood supply in patients with pancreasticobiliary maljunction. Shinozaki K, Ajiki T, Matsumoto T, Yoshida Y, Murakami S, Okazaki T, Toyama H, Matsumoto I, Fukumoto T, Ku Y. Surg Today 46: 169-175, 2016
  14. Reappraisal of total pancreatectomy in 45 patients with pancreatic ductal adenocarcinoma in the modern era using matched-paired analysis: Multicenter Study Group of Pancreatobiliary Surgery in Japan. Satoi S, Murakami Y, Motoi F, Sho M, Matsumoto I, Uemura K, Kawai M, Kurata M, Yanagimoto H, Yamamoto T, Mizuma M, Unno M, Kinoshita S, Akahori T, Shinzeki M, Fukumoto T, Hashimoto Y, Hirono S, Yamaue H, Honda G, Kwon M. Pancreas 45(7): 1003-1009, 2016
  15. Prognosis after surgical treatment for pancreatic cancer in patients aged 80 years or older: a multicenter study. Sho M, Murakami Y, Kawai M, Motoi F, Satoi S, Matsumoto I, Honda G, Uemura K, Yanagimoto H, Kurata M, Akahori T, Kinoshita S, Nagai M, Nishiwada S, Fukumoto T, Unno M, Yamaue H, Nakajima Y. J Hepatobiliary Pancreat Sci 23(3): 188-197, 2016
  16. The predictive powers of serum α-fetoprotein and Des-γ-carboxy prothrombin for survival varies by tumor size in hepatocellular carcinoma. Tsugawa D, Fukumoto T, Kido M, Takebe A, Tanaka M, Kuramitsu K, Matsumoto I, Ajiki T, Koyama T, Ku Y. Kobe J Med Sci 61(5): E124-131, 2016
  17. A novel technique for the intraoperative identification of biliary drainage areas in the liver after heaptobiliary resection for perihilar cholangiocarcinoma. Fukumoto T, Urade T, Kido M, Takebe A, Ajiki T, Toyama H, Matsumoto I, Ku Y. J Am Coll Surg 222(5): e31-38, 2016
  18. Recommendation of treatment strategy for postoperative hemorrhage: lessons from a single-center experience in 35 patients. Asari S, Matsumoto I, Toyama H, Yamaguchi M, Okada T, Shinzeki M, Goto T, Ajiki T, Fukumoto T, Ku Y. Pancreatology 16: 454-463, 2016
  19. Grade B pancreatic fistulas do not affect survival after pancreatectomy for pancreatic cancer: A multicenter observational study. Kawai M, Murakami Y, Motoi F, Sho M, Satoi S, Matsumoto I, Honda G, Hirono S, Okada KI, Unno M, Nakajima Y, Uemura K, Kwon AH, Fukumoto T, Kurata M, Yamaue H. Surgery 160(2): 293-305, 2016
  20. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomized, non-inferiority trial (JASPAC 01). Uesaka K, Boku N, Fukutomi A, Okamura Y, Konishi M, Matsumoto I, Kaneoka Y, Shimizu Y, Nakamori S, Sakamoto H, Morinaga S, Kaimura O, Imai K, Sata N, Hishimura S, Ojima H, Yamaguchi R, Hirano S, Sudo T, Ohashi Y. JASPAC 01 Study Group Lancet 16; 388 (10041): 248-257, 2016
  21. Second primary pancreatic ductal carcinoma in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma: High cumulative incidence rates at 5 years after pancreatectomy. Ishida J, Toyama H, Matsumoto I, Asari S, Goto T, Terai S, Nanno Y, Yamashita A, Mizumoto T, Ueda Y, Kido M, Ajiki T, Fukumoto T, Ku Y.
    Pancreatology 16(4): 615-620, 2016
  22. Hemorrhagic and thromboembolic complications after hepato-billiary-pancreatic surgery in patients receiving antithrombotic therapy. Ishida J, Fukumoto T, Kido M, Matsumoto I, Ajiki T, Kawai H, Hirata K, Ku Y. Dig Surg 22; 34(2): 114-124, 2016

2015

  1. Proposed preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after surgical resection: A multi-center retrospective study. Matsumoto I, Murakami Y, Shinzeki M, Asari S, Goto T, Tani M, Motoi F, Uemura K, Sho M, Satoi S, Honda G, Yamaue H, Unno M, Akahori T, Kwon AH, Kurata M, Ajiki T, Fukumoto T, Ku Y. Pancreatology 15(6): 674-680, 2015
  2. Postoperative serum album level is a marker of incomplete adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma. Matsumoto I, Tanaka M, Shirakawa S, Shinzeki M, Toyama H, Asari S, Goto T, Yamashita H, Ishida J, Ajiki T, Fukumoto T, Shimokawa M, Ku Y. Ann Surg Oncol 22(7): 2408-2415, 2015
  3. The clinical risk score predicts the effectiveness of adjuvant chemotherapy for colorectal liver metastasis. Nakai T, Ishikawa H, Tokoro T, Okuno K. World J Surg 39(6): 1527-1536, 2015
  4. Perioperative management for pancreatoduodenectomy following severe acute pancreatitis in patients with periampullary cancer: our experience with six consecutive cases. Asari S, Matsumoto I, Ajiki T, Shinzeki M, Goto T, Fukumoto T, Ku Y. Surg Today 45(2): 181-188, 2015
  5. Reappraisal of peritoneal washing cytology in 984 patients with pancreatic ductal adenocaricinoma who underwent margin-nefative resection. Satoi S, Murakami M, Motoi F, Uemura K, Kawai M, Kurata M, Sho M, Matsumoto I, Yanagimoto H, Yamamoto T, Mizuma M, Unno M, Hashimoto Y, Hirono S, Yamaue H, Honda G, Nagai M, Nakajima Y, Shinzeki M, Fukumoto T, Kwon AH. J Gastrointest Surg 19(1): 6-14, 2015
  6. Postoperative prognosis of pancreatic cancer with para-aortic lymph node metastasis: a multicenter study on 822 patients. Sho M, Murakami Y, Motoi F, Satoi S, Matsumoto I, Kawai M, Honda G, Uemura K, Yanagimoto H, Kurata M, Fukumoto T, Akahori T, Kinoshita S, Nagai M, Nishiwada S, Unno M, Yamaue H, Nakajima Y. J Gastroenterol 50(6): 694-702, 2015
  7. Acute graft-versus-host disease following simultaneous pancreas-kidney transplantation: report of a case. Asari S, Matsumoto I, Toyama H, Shinzeki M, Goto T, Tanaka M, Shirakawa S, Yamashita H, Ajiki T, Fukumoto T, Ku Y. Surgery Today 45(12): 1567-1571, 2015
  8. Portal or superior mesenteric vein resection in pancreastoduodenectomy for pancreastic head carcinoma. Murakami Y, Satoi S, Motoi F, Sho M, Kawai M, Matsumoto I, Honda G; Multicentre Study Group of Pancreatobiliary Surgery (MSG-PBS). Br J Surg 102(7): 837-846, 2015
  9. Impact of preoperative biliary drainage on long-term survival in resected pancreatic ductal adenocarcinoma: A multicenter observational study. Uemura K, Murakami Y, Saito S, Sho M, Motoi F, Kawai M, Matsumoto I, Honda G, Kurata M, Yanagimoto H, Nishiwada S, Fukumoto T, Unno M, Yamaue H. Ann Surg Oncol 22: S1238-S1246, 2015
  10. National Comprehensive Cancer Network resectability status for pancreatic carcinoma predicts overall survival. Murakami Y, Satoi S, Sho M, Motoi F, Matsumoto I, Kawai M, Honda G, Uemura K, Yanagimoto H, Shinzeki M, Kurata M, Kinoshita S, Yamaue H, Unno M. World J Surg 39(9): 2306-2314, 2015
  11. Do patients with small solitary hepatocellular carcinomas without mascoscopically vascular invasion require anatomic resection? Propensity score analysis. Hirokawa F, Kubo S, Nagano H, Nakai T, Kaibori M, Hayashi M, Tanemura S, Wada H, Nakata Y, Matsui K, Ishizaki M, Uchiyama K. Surgery 157(1): 27-36, 2015
  12. Late-onet bile leakage after heaptic resection. Kaibori M, Shimizu J, Hayashi M, Nakai T, Ishizaki M, Matsui K, Kim YK, Hirokawa F, Nakata Y, Noda T, Dono K, Nozawa A, Kwon M, Uchiyama K, Kubo S. Surgery 157(1): 37-44, 2015

2014

  1. Hypoxia induces resistance to ALK inhibitors in the H3122 non-small cell lung cancer cell line with an ALK rearrangement via epithelial-mesenchymal transition. Kogita A, Togashi Y, Sogabe S, Terashima M, De Velssco MA, Sakai K, Fujita Y, Tomida S, Takeyama Y, Okuno K, Nakagawa K, Nishio K. Int J Oncol 45(4): 1430-1436, 2014
  2. A prospective randomized comparison between pylorus- and subtotal stomach-preserving pancreatoduodenectomy on postoperative delayed gastric emptying occurrence and long-term nutritional status. Matsumoto I, Shinzeki M, Asari S, Goto T, Shirakawa S, Ajiki T, Fukumoto T, Suzuki Y, Ku Y. J Surg Oncol 109(7): 690-696, 2014
  3. Evaluation of glucose metabolism after distal pancreatectomy according to the donor criteria of the living donor pancreas transplantation guidelines proposed by the Japanese Pancreas and Islet Transplantation Association. Matsumoto I, Shinzeki M, Asari S, Goto T, Shirakawa S, Ajiki T, Fukumoto T, Ku Y. Transplant Proc 46(3): 958-962, 2014
  4. Functioning graft pancreas with thromboses of splenic and superior mesenteric arteries after simultaneous pancreas-kidney transplantation: A case report. Matsumoto I, Shinzeki M, Asari S, Goto T, Shirakawa S, Ajiki T, Fukumoto T, Ku Y. Transplant Proc. 46(3): 989-991, 2014
  5. Phase I clinical trial of vaccination with LY6K-derived peptide in patients with advanced gastric cancer. Ishikawa H, Imano M, Shiraishi O, Yasuda A, Peng YF, Shinkai M, Yasuda T, Imamoto H, Shiozaki H. Gastric Cancer 17(1): 173-180, 2014
  6. Curative resection of hilar cholangiocarcinoma in a 25-year-old woman: report of a case
    Murakami S, Ajiki T, Ueno K, Sawa H, Tsuchida S, Otsubo I, Yoshida Y, Shinozaki K, Okazaki T, Matsumoto I, Fukumoto T, Ku. Surg Today 44(7): 1350-1354, 2014
  7. Contrast-enhanced intraoperative ultrasonic cholangiography for real time biliary navigation in hepatobiliary surgery. Urade T, Fukumoto T, Tanaka M, Kido M, Takebe A, Kuramitsu, Chuma M, Matsumoto I, Ajiki T, Ku Y. J Am Coll Surg 218(2): e43-50, 2014
  8. Long-term outcomes and prognostic factors with reductive hepatectomy and sequential percutaneous isolated hepatic perfusion for multiple bilobar hepatocellular carcinoma. Fukumoto T, Tominaga M, Kido M, Takebe A, Tanaka M, Kuramitsu K, Matsumoto I, Ajiki T, Ku Y. Ann Surg Oncol 21(3): 971-978, 2014
  9. Influence of preoperative anti-cancer therapy on respectability and perioperative outcomes in patients with pancreatic cancer: Project study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery. Motoi F, Unno M, Takahashi H, Okada T, Wada K, Sho M, Nagano H, Matsumoto I, Satoi S, Murakami Y, Kishiwada M, Honda G, Kinoshita H, Baba H, Hishinuma S, Kitago M, Tajima H, Shinchi H, Takamori H, Kosuge T, Yamaue H, Takada T. J Hepatobiliary Pancreat Sci 21(2): 148-158, 2014
  10. Two-layer challenge test as an assessment to predict islet graft function. Goto T, Fujino Y, Kanashiro M, Tanioka M, Sakai T, Yoshikawa T, Matsumoto I, Suzuki Y, Ku Y, Kuroda Y. Hepatogastroenterology 61(130): 502-506, 2014
  11. Factors affecting survival after resection of intrahepatic cholangiocaricinoma. Murakami S, Ajiki T, Okazaki T, Ueno K, Kido M, Matsumoto I, Fukumoto T, Ku Y. Surg Today 44(10): 1847-1854, 2014
  12. Short- and Long-term Results of Extended Drainage Procedure for Chronic Pancreatitis: A Retrospective Japanese Single-Center Study. Tanaka M, Matsumoto I, Shinzeki M, Asari S, Goto T, Yamashita H, Ishida J, Ajiki T, Fukumoto T, Ku Y. Kobe J. Med.Sci 20; 60(2): W30-36, 2014
  13. Long-term complications after liver transplantation. Kuramitsu K, Fukumoto T, Iwasaki T, Tominaga M, Matsumoto I, Ajiki T, Ku Y. Transplant Proc 46(3): 797-803, 2014
  14. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms. Kamata K, Kitano M, Kudo M, Sakamoto H, Kadosaka K, Miyata T, Imai H, Maekawa K, Chikugo T, Kumano M, Hyodo T, Murakami T, Chiba Y, Takeyama Y. Endoscopy 46(1): 22-29, 2014
  15. Higher complication rate in hepatocellular carcinoma patients undergoing prophylactic cholecystectomy with curative hepatic resection. Kaibori M, Kubo S, Nagano H, Hayashi M, Nakai T, Ishizaki M, Uchiyama K, Kwon M. Hepatogastroenterology 61: 2028-2034, 2014
  16. Gastrointestional stromal tumors with exon 8 c-kit gene mutation might occur at extragastric sites and have metastasis-prone nature. Ito Y, Yamamura M, Hirai T, Ishikawa T, Kanda T, Nakai T, Ohkouchi M, Hashikura Y, Isoakai K, Hirota S. Int J Clin Exp Pathol 15: 8024-8031, 2014
  17. Genome-wide profiling of DNA methylation and tumor progression in human hepatocellular carcinoma. Nishida M, Nishimura T, Nakai T, Chishina H, Arizumi T, Yada N, Hagiwara S, Minami Y, Ueshima K, Kudo M. Dig Dis 32: 658-663, 2014
  18. High survival in patients operated for small isolated liver metastases from gastric cancer: a multicenter institutional study. Komeda K, Hayashi M, Kubo S, Nagano H, Nakai T, Kaibori M, Hirokawa F, Kwon AH, Uchiyama K. World J Surg 38: 2692-2697, 2014

2013

  1. A case of adenocarcinoma of the duodenum arising from Brunner's gland. Yasuda T, Kamei K, Araki M, Nakata Y, Ishikawa H, Yamazaki M, Sakamoto H, Kitano M, Nakai T, Takeyama Y. Case Rep Gastroenterol 7: 433-437, 2013
  2. Extraperotpneal fluid collection due to chronic pancreatitis. Yasuda T, Kamei K, Araki M, Nakata Y, Ishikawa H, Yamazaki M, Sakamoto H, Kitano M, Nakai T, Takeyama Y. Case Rep Gastroenterol 7: 322-326, 2013
  3. Unresectable colorectal liver metastases: the safety and efficacy of conversion therapy using hepatic arterial infusion immunochemotherapy with 5-fluorouracil and polyethylene glycol-interferon α-2a. Nakai T, Okuno K, Kitaguchi H, Ishikawa H, Yamasaki M. World J Surg 37(8): 1919-1926, 2013
  4. Clinicopathological features of recurrence in patients after 10-year disease-free survival following curative hepatic resection of hepatocellular carcinoma. Kaibori M, Kubo S, Nagano H, Hayashi M, Haji S, Nakai T, Ishizaki M, Matsui K, Uenishi T, Takemura S, Wada H, Marubashi S, Komeda K, Hirokawa F, Nakata Y, Uchiyama K, Kwon AH. World J Surg 37(4): 820-828, 2013
  5. Criteria for the diagnosis and severity stratification of acute pancreatitis. Otsuki M, Takeda K, Matsuno S, Kihara Y, Koizumi M, Hirota M, Ito T, Kataoka K, Kitagawa M, Inui K, Takeyama Y. World J Gastroenterol, 19(35), 5798-5805, 2013

2012

  1. Gastrointestinal bleeding as the initial manifestation of pancreatic adenocarcinoma successfully treated by emergency pancreaticoduodenectomy. Kamei K, Yasuda T, Nakata Y, Yamazaki M, Ishikawa H, Nkai T, Takeyama Y. ACTA Med Kinki Univ 37(2): 81-90, 2012
  2. COX-2 expression and the prevalence of regulatory T cells in tumor and non-tumor sites of hepatocellular carcinoma. Nakata Y, Takeyama Y, Haji S, Arai M, Yasuda Y, Nakai T, Okuno K, Shiozaki H. ACTA Med Kinki Univ 37(2): 81-90, 2012

2011

  1. Hepatocellular carcinoma accompanied by hypersplenism: five cases of simultaneous hepatectomy and laparoscopic splenectomy. Nakata Y, Haji S, Yamasaki M, Ishikawa H, Yasuda T, Nakai T, Takeyama Y. Acta Med Kinki Univ 36(2): 81-86, 2011

2010

  1. Significant expression of interleukin-15 in rat experimental severe acute pancreatitis. Kamei K, Yasuda T, Ueda T, Fu Q, Shiozaki H, Ohyanagi H, Takeyama Y. Eur Surg Res 44: 159-169, 2010
  2. Two cases of hepatocellular carcinoma located adjacent to the Glisson's capsule treated by laparoscopic radiofrequency ablation with intraductal chilled saline perfusion through an endoscopic nasobiliary drainage tube. Nakata Y, Haji S, Ishikawa H, Yasuda T, Nakai T, Takeyama Y, Shiozaki H. Surg Laparosc Endosc PercutanTech 20: 189-192, 2010
  3. Frey procedure for chronic pancreatitis in a child with duodenal atresia and complex pancreaticobiliary disorders. Okuyama H, Kubata A, Takeyama Y, et al. Eur J Pediatr Surg 20(1): 45-47, 2010
  4. In vivo evaluation of microspheres containing the angiogenesis inhibitor, TNP-470, and the metastasis suppression with liver metastatic model implanted neuroblastoma. Yasuda C, Sakata S, Kakinoki S, Takayama Y, Ohyanagi H, Shiozaki H. Pathophysiology 17(2): 149-155, 2010
  5. Role of triggering receptor expressed on myeloid cells-1 in experimental severe acute pancreatitis. Kamei K, Yasuda T, Ueda T, Fu Q, Takeyama Y, Shiozaki H. J Hepatobiliary Pancreat Sci 17(3): 305-312, 2010

2009

  1. Long-term prognosis of acute pancreatitis in Japan. Clinical Gasteroenterol and Hepatol Takeyama Y. 7(11 suppl): S15-17, 2009
  2. Small invasive ductal carcinoma of the pancreas distinct from branch duct intraductal papillary mucinous neoplasm. Sakamoto H, Kitano M, Takeyama Y, Kudo M, et al. World J Gastroenterol 15(43): 5489-5492, 2009
  3. Cystic nonfunctioning pancreatic endocrine neoplasm presenting the communication with main pancreatic duct. Kamei K, Yasuda T, Shinzaki W, Satoi S, Ueda T, Takeyama Y. Dig Surg 26:25-26, 2009
  4. Involvement of osteopontin as a core protein in cholesterol gallstone formation. Ishikawa H, Imano M, Takeyama Y, Shiozaki H, Ohyanagi H. J Hepatobiliary Pancreat Surg 16(2): 197-203. 2009
  5. Utility of new Japanese severity score and indication for special therapies in acute pancreatitis. Ueda T, Takeyama Y, Yasuda T, Kamei K, Satoi S, et al. J Gastroenterol 44(5): 453-9, 2009
  6. Plasma tissue factor pathway inhibitor levels in patients with acute pancreatitis. Yasuda T, Ueda T, Kamei K, Shinzaki W, Sawa H, Shinzeki M, Ku Y, Takeyama Y. J Gastroenterol 44(10): 1071-1079, 2009
  7. Early infection to peripancreatic tissue in mild acute pancreatitis: report of a case. Kamei K, Takeyama Y, Yasuda T, Kawasaki M, Ueda T, Ohyanagi H, Shiozaki H. Surg Today 39(12): 1083-1085, 2009
  8. Prospective comparative study of the EUS guided 25-gauge FNA needle with the 19-gauge Trucut needle and 22-gauge FNA needle in patients with solid pancreatic masses. Sakamoto H, Kitano M, Takeyama Y, Kudo M, et al. J Gastroenterol Hepatol 24(3): 384-390, 2009
  9. Laparoscopic excision of an epidermoid cyst arising from the deep abdominal wall. Ishikawa H, Nakai T, Ueda K, Haji S, Takeyama Y, Ohyanagi H. Surg Laparosc Endosc Percutan Tech 19(5): e221-224, 2009
  10. In situ carcinoma of pancreas diagnosed by EUS-FNA. Sakamoto H, Kitano M, Takeyama Y, Kudo M, et al. Endoscopy 40 (Suppl 2); E15-16, 2009
  11. An immunohistochemical study of osteopontin in hepatolithiasis. Nakai, A, Imano, M, Takeyama, Y, Shiozaki, H, Ohyanagi, H. J Hepatobiliary Pancreat Surg 15(6): 615-621, 2009

このページの最上部へ戻る